Insider buying · SEC Form 4

Insider Buying — Jul 6, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

8insider buys
$6.44Mbought in total
6companies
3by CEOs, CFOs and other chiefs
HDSNlargest: $1.62M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
HDSNHudson Technologies Inc.Hartree Partners LP10% Owner$1.62M271,302$5.97AddedJul 5, 2026
Confirmed July 5 (Saturday) EDGAR filing. Part of 3-tranche accumulation: 204,789 shares Jun 30 + 288,111 shares Jul 1 + 271,302 shares Jul 2 = 764,202 total shares (~$4.5M). Avg buy $5.97; now $5.99 (+0.3%). Hartree stake now ~11.8%. EPA HFC phase-down tailwind.
WBXWallbox N.V.Pedro Alonso AgueraDirector$1.36M501,361$2.72AddedJul 2, 2026
Bought Jun 30 at $2.72 avg, same day Spanish court finalized €15.8M restructuring. Now $4.16 (+52.9%). Cluster buy alongside CEO Escorsa. Post-restructuring insider conviction.
NVCTNuvectis Pharma Inc.Marlio Charles Mosseri10% Owner$916K50,000$18.32AddedJul 2, 2026
Bought Jun 30 at $18.32 avg (range $18.29–$18.32). Now $19.57 (+6.8%). Post-offering cluster buy alongside CEO Bentsur ($250K). Precision oncology biotech. Total insider cluster ~$1.17M.
WBXWallbox N.V.Enric Asuncion EscorsaCEO$886K325,885$2.72AddedJul 4, 2026
Bought Jun 30 at $2.72 avg, same day as Director Aguera. Now $4.16 (+52.9%). Combined WBX insider cluster (CEO + Director) = $2.25M. Post-restructuring conviction buy.
JCTCJewett-Cameron Trading Co. Ltd.Adam James Bradley10% Owner$806K353,607$2.28AddedJul 2, 2026
Form 4 ↗
Purchased Jun 29 at $2.28 avg by AJB Investment Fund II LP, AJB Capital LLC, Adam James Bradley, and Melinda Hodges Bradley collectively. AJB group now ~10.9% of JCTC. Now $2.56 (+12.3%). Block size unusual relative to market cap — possible strategic intent.
FTHFaeth Therapeutics Inc.Brian C. StephensonCFO$326K13,634$23.92AddedJul 3, 2026
Purchases Jun 29–Jul 1 at $22.95–$24.98 range (~$23.92 avg) via Brian Stephenson Revocable Trust. Now $22.92 (-4.2%). Sixth consecutive week of open-market CFO buying — cumulative personal investment >$1M. Precision oncology (formerly Sensei Biotherapeutics).
BOLDBoundless Bio Inc.Kevin Tang10% Owner$269K107,363$2.50AddedJul 3, 2026
Purchased Jun 30–Jul 2 at $2.49–$2.54 avg via Tang Capital Management LLC. Tang stake now ~11.3% (2.64M shares). Now $2.50 (0.0%). Extrachromosomal DNA (ecDNA) oncology platform.
NVCTNuvectis Pharma Inc.Ron BentsurChairman & CEO$250K12,500$20.00AddedJul 1, 2026
Bought at $20.00 (public offering price, Jun 29–Jul 1 window). Now $19.57 (-2.2%). Cluster buy alongside 10% owner Mosseri. Combined NVCT insider cluster = $1.17M. Note: may be offering-price buy (verify transaction code).

AIThe day in insider buying

SEC Form 4 Insider Scan — July 6, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 8 qualifying buys (≥ $250K, transaction type P) totalling $6.44M. Note: July 4 (Independence Day) and July 5–6 (weekend) produced minimal EDGAR traffic; this batch spans June 29 – July 5, covering the complete holiday-shortened week with July 5 (Saturday) being the only confirmed new filer (Hartree/HDSN).

Headline filings

  • HDSN — Hartree Partners LP (10% Owner) bought 271,302 shares ≈ $1.62M at $5.97 avg; now $5.99 (+0.3% since buy). Confirmed July 5 weekend filing; part of a 3-day multi-tranche accumulation of 764K shares (~$4.5M total across Jun 30–Jul 2). Refrigerant reclaimer benefiting from EPA HFC phase-down. (filing)
  • WBX — Pedro Alonso Aguera (Director) bought 501,361 shares ≈ $1.36M at $2.72 avg; now $4.16 (+52.9% since buy). Post-restructuring cluster buy the day the Spanish court approved Wallbox's €15.8M recapitalization. Already up over 50% in six days. (filing)
  • NVCT — Marlio Charles Mosseri (10% Owner) bought 50,000 shares ≈ $916K at $18.32 avg; now $19.57 (+6.8% since buy). Cluster buy paired with CEO Bentsur's same-week purchase — two insiders loading up post-offering in this precision-oncology biotech. (filing)
  • WBX — Enric Asuncion Escorsa (CEO) bought 325,885 shares ≈ $886K at $2.72 avg; now $4.16 (+52.9% since buy). Same conviction buy as the Director — CEO and board member both bought the day restructuring closed. (filing)
  • JCTC — Adam James Bradley / AJB Capital (10% Owner) bought 353,607 shares ≈ $806K at $2.28 avg; now $2.56 (+12.3% since buy). AJB entities now hold ~10.9% of Jewett-Cameron; block is unusually large relative to market cap and may signal strategic intent. (filing)
  • FTH — Brian C. Stephenson (CFO) bought 13,634 shares ≈ $326K at $23.92 avg; now $22.92 (−4.2% since buy). Sixth consecutive week of open-market buying by the Faeth Therapeutics CFO via personal trust — cumulative personal investment now exceeds $1M. (filing)
  • BOLD — Kevin Tang / Tang Capital (10% Owner) bought 107,363 shares ≈ $269K at $2.50 avg; now $2.50 (0.0% since buy). Tang Capital continues building its 11.3% Boundless Bio stake over three consecutive days around the offering window. (filing)
  • NVCT — Ron Bentsur (CEO) bought 12,500 shares ≈ $250K at $20.00 avg; now $19.57 (−2.2% since buy). CEO purchased at the offering price alongside 10% owner Mosseri — classic post-dilution vote of confidence. (filing)

Notes

Holiday-week context: The July 4 federal holiday (Friday) compressed the trading week to 3.5 days. Hartree Partners is the sole confirmed weekend filer (Jul 5, Saturday). Remaining filings are from July 1–3 trailing edge. Next batch of Form 4s for July 3 trades is due by July 7–8.

WBX cluster is the standout of the week: Wallbox CEO + Director both bought at $2.72 on June 30, the same day the Spanish court finalized the company's debt-to-equity restructuring. The stock has surged +53% to $4.16 as of this scan — both insiders are already deeply in the green on 6-day-old positions.

Refrigerant play (HDSN): Hartree accumulated 764K shares (~$4.5M total) across three days, pushing its stake past 11.8%. Hudson Technologies reclaims and recycles HFCs; EPA's accelerated phase-down schedule makes reclaimed refrigerant increasingly scarce and valuable.

NVCT biotech cluster: CEO and a major shareholder both bought within days of a $20 public offering — combined ~$1.17M invested. Insiders frequently buy alongside offerings they believe are priced at a discount to intrinsic value.

Serial CFO buyer (FTH): Faeth Therapeutics (precision oncology, formerly Sensei Biotherapeutics) has a new management team that has been buying aggressively since installation. The CFO's 6-week streak of open-market buys through a personal revocable trust is an unusually strong repeated conviction signal.

JCTC strategic stake: AJB Capital's $806K block lifts their JCTC stake to ~10.9% — likely the precursor to a board seat demand or takeout offer on this small-cap fencing and industrial products company.

Most-bought stocks, last 30 days

  • HOOD $35.3M · 2 buysRobinhood Markets, Inc.
  • ARTV $16.6M · 3 buys, 3 insidersArtiva Biotherapeutics Inc.
  • NSP $15.9M · 2 buysInsperity Inc.
  • AVO $14.4M · 6 buys, 3 insidersMission Produce Inc
  • PBLS $10.2M · 2 buys, 2 insidersParabilis Medicines, Inc.
  • STEP $10.0M · 2 buysStepStone Group Inc.
  • PSEC $9.35M · 3 buys, 2 insidersProspect Capital Corp
  • TXO $8.23M · 1 buyTXO Partners, L.P.
  • FUN $5.90M · 1 buySix Flags Entertainment Corporation
  • SMMT $3.64M · 3 buys, 3 insidersSummit Therapeutics Inc.
  • NVCT $3.50M · 6 buys, 2 insidersNuvectis Pharma Inc.
  • COE $3.25M · 1 buy51Talk Online Education Group
  • FISV $3.25M · 7 buys, 4 insidersFiserv Inc.
  • LODE $2.89M · 2 buys, 2 insidersComstock Inc.
  • AII $2.30M · 1 buyAmerican Integrity Insurance Group, Inc.
  • WBX $2.25M · 2 buys, 2 insidersWallbox N.V.
  • FCNCA $2.04M · 2 buysFirst Citizens BancShares Inc.
  • AMR $2.01M · 1 buyAlpha Metallurgical Resources Inc.
  • GPGI $1.99M · 2 buysGPGI, Inc.
  • NXST $1.99M · 1 buyNexstar Media Group, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.